On August 28, 2020, three companies within the fund-of-funds portfolio managed by Yuanhe Chencun simultaneously listed on exchanges in both China and the U.S.

Among them, two companies are listed on China's STAR Market: Shengxiang Biotechnology Co., Ltd. (referred to as "Shengxiang Bio," stock code "688289.SH"), and Suzhou Green Harmonic Drive Technology Co., Ltd. (referred to as "Green Harmonic," stock code "688017.SH"). Additionally, Guangzhou Chengxing Zhidong Automotive Technology Co., Ltd. (referred to as "XPeng Motors," stock code "XPEV.NYSE") is listed on the U.S. stock market.

Shengxiang Biotechnology is an integrated provider of in-vitro diagnostic (IVD) solutions, focusing on independently innovative gene technologies and offering comprehensive services that encompass the research & development, manufacturing, sales of diagnostic reagents and instruments, as well as third-party medical testing services.

Green Harmonic is a high-tech enterprise specializing in the research, development, design, manufacturing, and sales of precision transmission devices. Its product portfolio includes harmonic reducers, mechatronic actuators, and high-precision components—products that are widely used in advanced manufacturing sectors such as industrial robots, service robots, CNC machine tools, aerospace, medical equipment, semiconductor manufacturing systems, and new energy technologies.

Xpeng Motors is a leading Chinese designer and manufacturer of intelligent electric vehicles, as well as a technology company at the forefront of cutting-edge internet and AI innovation. Committed to driving transformation in smart electric mobility through data-driven insights, Xpeng is reshaping the future of how we move.